Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanyou Bio Launches AI-Powered Antibody Design Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sanyou Bio Launches AI-Powered Antibody Design Platform

OneClick+ offers a comprehensive suite of tools for creating various antibody formats.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. has introduced the “Sanyou Innovative Intelligent Antibody Design oneClick+ Platform,” an artificial intelligence-powered platform designed to expedite antibody development. The platform incorporates a vast database of antibody structures, enabling researchers to efficiently design and analyze potential antibody candidates.
 
OneClick+ offers a comprehensive suite of tools for creating various antibody formats, including IgG-like antibodies, nanobodies, and single-chain variable fragments. Users can input complete or partial antibody sequences and leverage the platform’s capabilities to generate detailed reports on physicochemical properties, potential mutations, and structural visualizations.
 
By automating many of the time-consuming tasks associated with antibody design, Sanyou aims to streamline the drug development process for its clients. The company believes that oneClick+ will be a valuable asset for researchers seeking to accelerate the creation of novel therapeutics.
 
“The launch of the ‘oneClick+’ platform marks a significant step forward for Sanyou Bio in the field of intelligent antibody design,” said Dr. Guojun Lang, CEO of Sanyou Bio. “The convenience it offers will completely revolutionize the way users approach antibody design. We believe that the launch of the ‘oneClick+’ platform will provide our customers with an unprecedented experience and contribute to the intelligent development of the biopharmaceutical industry.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics